ArticleNature communications2026

Enzymatic activity-independent NANS stabilizes LATS2 to drive growth and therapeutic resistance in HR+/HER2- breast cancer.

Jia-Yang Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.